Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Molecules ; 26(18)2021 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-34577068

RESUMEN

The regulation of intestinal colonization in livestock by means of non-bactericidal additives is an important management lever for zoonotic bacteria such as Salmonella spp. Caenorhabditis elegans is proposed here as a model for the evaluation of five essential oils (EOs) as anti-colonization products against Salmonella Typhimurium. An evaluation of the toxicity of EOs for C. elegans showed LD50 values ranging from 74.5 ± 9.6 µg/mL for Cinnamomum cassia (CEO) to 271.6 ± 14.9 µg/mL for Syzygium aromaticum (SyEO). Both EOs significantly inhibited bacterial colonization in the digestive tract of C. elegans with reductions of 0.88 and 0.70 log CFU/nematode at nontoxic concentrations of 50 µg/mL and 150 µg/mL, respectively. With the minimal bactericidal concentrations of CEO and SyEO against S. Typhimurium being 312.5 µg/mL and 625 µg/mL, respectively, an antibacterial effect can be excluded to explain the inhibition of the bacterial load. The anti-colonizing activity of these two EOs could, however, be related to an inhibition of the swimming motility, which was significantly reduced by 23.47% for CEO at 50 µg/mL and 19.56% for SyEO at 150 µg/mL. This study shows the potential of C. elegans as a predictive in vivo model of anti-colonizing activities that is suitable for the evaluation of essential oils.


Asunto(s)
Antibacterianos/farmacología , Cinnamomum aromaticum/química , Aceites Volátiles/farmacología , Extractos Vegetales/farmacología , Infecciones por Salmonella/tratamiento farmacológico , Syzygium/química , Animales , Antibacterianos/uso terapéutico , Carga Bacteriana/efectos de los fármacos , Caenorhabditis elegans , Intestinos/microbiología , Aceites Volátiles/uso terapéutico , Extractos Vegetales/uso terapéutico , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/patogenicidad
2.
Molecules ; 26(16)2021 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-34443349

RESUMEN

Ulva sp. is known to be a source of bioactive compounds such as ulvans, but to date, their biological activity on skin commensal and/or opportunistic pathogen bacteria has not been reported. In this study, the effects of poly- and oligosaccharide fractions produced by enzyme-assisted extraction and depolymerization were investigated, for the first time in vitro, on cutaneous bacteria: Staphylococcus aureus, Staphylococcus epidermidis, and Cutibacterium acnes. At 1000 µg/mL, poly- and oligosaccharide fractions did not affect the growth of the bacteria regarding their generation time. Polysaccharide Ulva sp. fractions at 1000 µg/mL did not alter the bacterial biofilm formation, while oligosaccharide fractions modified S. epidermidis and C. acnes biofilm structures. None of the fractions at 1000 µg/mL significantly modified the cytotoxic potential of S. epidermidis and S. aureus towards keratinocytes. However, poly- and oligosaccharide fractions at 1000 µg/mL induced a decrease in the inflammatory potential of both acneic and non-acneic C. acnes strains on keratinocytes of up to 39.8%; the strongest and most significant effect occurred when the bacteria were grown in the presence of polysaccharide fractions. Our research shows that poly- and oligosaccharide Ulva sp. fractions present notable biological activities on cutaneous bacteria, especially towards C. acnes acneic and non-acneic strains, which supports their potential use for dermo-cosmetic applications.


Asunto(s)
Bacterias/efectos de los fármacos , Bacterias/crecimiento & desarrollo , Microbiota/efectos de los fármacos , Extractos Vegetales/farmacología , Piel/microbiología , Ulva/química , Bacterias/patogenicidad , Relación Dosis-Respuesta a Droga , Propionibacteriaceae/efectos de los fármacos , Propionibacteriaceae/crecimiento & desarrollo , Propionibacteriaceae/patogenicidad , Propionibacteriaceae/fisiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Staphylococcus aureus/patogenicidad , Staphylococcus aureus/fisiología , Staphylococcus epidermidis/efectos de los fármacos , Staphylococcus epidermidis/crecimiento & desarrollo , Staphylococcus epidermidis/patogenicidad , Staphylococcus epidermidis/fisiología , Virulencia/efectos de los fármacos
3.
J Biotechnol ; 303: 65-71, 2019 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-31369773

RESUMEN

Nowadays, research concerning immunomodulatory products are of great interest, particularly in the treatment of inflammatory diseases or the prevention of infectious diseases. These activities are usually evaluated on cell cultures, by tracking different factors requiring dedicated manipulation. Evaluation of the immunomodulatory activities of essential oils and pure compounds using several technics adapted to high content analysis is described in this study. This approach allows a multiparametric evaluation on a single cell batch, in order to obtain an overall response. The developed method is based on the simultaneous evaluation of phagocytosis, production of iNOS and secretion of IL-6, induced by contact of RAW 264.7 cells with LPS. The results highlight the immunomodulatory activities of cinnamon and clove essential oils. They also provide information, particularly concerning the inhibitory activity of mint essential oil, which inhibits the LPS-induced phagocytosis of RAW 264.7 cells by 42%, at 100 µg/ml. This work presents for the first time the adaptation of high content analyses for the monitoring of immunomodulatory activities of essential oils. This protocol could be adjustable to other cell types and supplemented by the evaluation of additional parameters.


Asunto(s)
Inflamación/inmunología , Lipopolisacáridos/efectos adversos , Aceites Volátiles/farmacología , Animales , Cinnamomum zeylanicum/química , Aceite de Clavo/farmacología , Relación Dosis-Respuesta a Droga , Inflamación/tratamiento farmacológico , Mentha/química , Ratones , Fagocitosis/efectos de los fármacos , Aceites de Plantas/farmacología , Células RAW 264.7
4.
Mar Drugs ; 16(12)2018 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-30563236

RESUMEN

Marine macroalgae (seaweed) are an excellent source of novel bioactive metabolites. The biorefinery concept applied to seaweed facilitates the extraction of many chemical constituents from the same biomass ensuring that the resource is used fully, generating few residues through a succession of extraction steps. In the present study, the biomass of the carragenophyte Solieria filiformis (Rhodophyta, Gigartinales) cultured in an integrated multi-trophic aquaculture (IMTA) system was evaluated to obtain valuable products by a biorefinery approach. Enzymatic-assisted extraction (EAE) and microwave-assisted extraction (MAE) were the eco-friendly technologies used to ensure an environmentally friendly valorization of the biomass. Three valuable products were successfully recovered: a water-soluble extract rich in proteins and sulfated polysaccharides suitable as a food supplement; a lipid fraction rich in polyunsaturated fatty acids (PUFAs) with potential to be used in the nutraceutical industry; and a pure ι-carrageenan with a powerful antiviral activity against Herpes simplex virus (EC50 = 6.3 µg mL-1) comparable to the commercial antiviral acyclovir (EC50 = 3.2⁻5.4 µg mL-1).


Asunto(s)
Acuicultura/métodos , Productos Biológicos/aislamiento & purificación , Reactores Biológicos , Extractos Vegetales/aislamiento & purificación , Rhodophyta/química , Algas Marinas/química , Aciclovir/farmacología , Animales , Antivirales/química , Antivirales/aislamiento & purificación , Antivirales/farmacología , Productos Biológicos/química , Productos Biológicos/farmacología , Biomasa , Carragenina/química , Carragenina/aislamiento & purificación , Carragenina/farmacología , Suplementos Dietéticos , Enzimas/química , Ácidos Grasos Insaturados/química , Ácidos Grasos Insaturados/aislamiento & purificación , Microondas , Perciformes/metabolismo , Extractos Vegetales/química , Extractos Vegetales/farmacología , Polisacáridos/química , Polisacáridos/aislamiento & purificación , Rhodophyta/metabolismo , Pepinos de Mar/metabolismo , Algas Marinas/metabolismo , Simplexvirus/efectos de los fármacos , Agua/química
5.
Mar Drugs ; 13(1): 558-80, 2015 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-25603348

RESUMEN

Codium fragile and Chondrus crispus are, respectively, green and red seaweeds which are abundant along the North Atlantic coasts. We investigated the chemical composition and antiviral activity of enzymatic extracts of C. fragile (CF) and C. crispus (CC). On a dry weight basis, CF consisted of 11% protein, 31% neutral sugars, 0.8% sulfate, 0.6% uronic acids, and 49% ash, while CC contained 27% protein, 28% neutral sugars, 17% sulfate, 1.8% uronic acids, and 25% ash. Enzyme-assisted hydrolysis improved the extraction efficiency of bioactive materials. Commercial proteases and carbohydrases significantly improved (p ≤ 0.001) biomass yield (40%-70% dry matter) as compared to aqueous extraction (20%-25% dry matter). Moreover, enzymatic hydrolysis enhanced the recovery of protein, neutral sugars, uronic acids, and sulfates. The enzymatic hydrolysates exhibited significant activity against Herpes simplex virus (HSV-1) with EC50 of 77.6-126.8 µg/mL for CC and 36.5-41.3 µg/mL for CF, at a multiplicity of infection (MOI) of 0.001 ID50/cells without cytotoxity (1-200 µg/mL). The extracts obtained from proteases (P1) and carbohydrases (C3) were also effective at higher virus MOI of 0.01 ID50/cells without cytotoxity. Taken together, these results indicate the potential application of enzymatic hydrolysates of C. fragile and C. crispus in functional food and antiviral drug discovery.


Asunto(s)
Antivirales/aislamiento & purificación , Chlorophyta/química , Chondrus/química , Herpesvirus Humano 1/efectos de los fármacos , Extractos Vegetales/aislamiento & purificación , Proteínas Algáceas/aislamiento & purificación , Proteínas Algáceas/farmacología , Antivirales/farmacología , Hidrólisis , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA